H. Thomas

631 total citations
32 papers, 427 citations indexed

About

H. Thomas is a scholar working on Oncology, Reproductive Medicine and Surgery. According to data from OpenAlex, H. Thomas has authored 32 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Reproductive Medicine and 7 papers in Surgery. Recurrent topics in H. Thomas's work include Ovarian cancer diagnosis and treatment (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Intraperitoneal and Appendiceal Malignancies (5 papers). H. Thomas is often cited by papers focused on Ovarian cancer diagnosis and treatment (8 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Intraperitoneal and Appendiceal Malignancies (5 papers). H. Thomas collaborates with scholars based in United Kingdom, Australia and United States. H. Thomas's co-authors include Martin Gore, Angus McIndoe, S. Peter Eggleton, Desmond P.J. Barton, P. Vasey, P. Price, Andrew J.T. George, John D. Graham, James Paul and Karol Sikora and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and British Journal of Cancer.

In The Last Decade

H. Thomas

31 papers receiving 411 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Thomas United Kingdom 13 158 129 119 79 50 32 427
G Gargano Italy 14 100 0.6× 186 1.4× 92 0.8× 79 1.0× 32 0.6× 42 591
D S Alberts United States 11 151 1.0× 223 1.7× 86 0.7× 128 1.6× 40 0.8× 36 576
Chan Kk Malaysia 13 162 1.0× 169 1.3× 126 1.1× 126 1.6× 12 0.2× 26 576
Ruifang Xu China 12 58 0.4× 198 1.5× 76 0.6× 52 0.7× 51 1.0× 27 523
Yoshiya Miyahara Japan 11 124 0.8× 157 1.2× 67 0.6× 35 0.4× 15 0.3× 21 468
Ami Vaidya United States 10 241 1.5× 249 1.9× 182 1.5× 98 1.2× 66 1.3× 16 633
Stephanie A. Sullivan United States 15 106 0.7× 150 1.2× 90 0.8× 106 1.3× 28 0.6× 39 549
Sachiko Kimura Japan 13 96 0.6× 114 0.9× 28 0.2× 80 1.0× 27 0.5× 38 365
S. Matthews United States 14 288 1.8× 276 2.1× 47 0.4× 77 1.0× 36 0.7× 41 747
Ya-Min Cheng Taiwan 17 303 1.9× 429 3.3× 99 0.8× 78 1.0× 47 0.9× 36 920

Countries citing papers authored by H. Thomas

Since Specialization
Citations

This map shows the geographic impact of H. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Thomas more than expected).

Fields of papers citing papers by H. Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Thomas. The network helps show where H. Thomas may publish in the future.

Co-authorship network of co-authors of H. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of H. Thomas. A scholar is included among the top collaborators of H. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Thomas. H. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Thomas, H., D. Bissett, John F. Waterfall, et al.. (2007). First-into-man phase I and pharmacokinetic study of XR5944.14, a novel agent with a unique mechanism of action. British Journal of Cancer. 97(7). 844–850. 15 indexed citations
3.
4.
Zbar, Andrew P., H. Thomas, Robert W. Wilkinson, et al.. (2005). Immune responses in advanced colorectal cancer following repeated intradermal vaccination with the anti-CEA murine monoclonal antibody, PR1A3: results of a phase I study. International Journal of Colorectal Disease. 20(5). 403–414. 9 indexed citations
5.
Thomas, H., et al.. (2002). Good Cell Culture Practice (GCCP) - eine Initiative zur Standardisierung und Qualitaetssicherung von in vitro Arbeiten. Die Etablierung einer ECVAM Task Force.. Joint Research Centre (European Commission). 18(1). 75–78. 7 indexed citations
6.
Gore, Martin, R. Atkinson, H. Thomas, et al.. (2002). Results of ZD0473 in platinum-pretreated ovarian cancer: analysis according to platinum free interval. European Journal of Cancer. 38. S7–S12. 8 indexed citations
7.
Gore, Martin, R. Atkinson, H. Thomas, et al.. (2002). A phase II trial of ZD0473 in platinum-pretreated ovarian cancer. European Journal of Cancer. 38(18). 2416–2420. 24 indexed citations
8.
Thomas, H., et al.. (2001). Ovarian cancer chemotherapy. Cancer Treatment Reviews. 27(2). 99–109. 17 indexed citations
9.
Vasey, P., James Paul, Elizabeth Junor, et al.. (1999). Docetaxel and Cisplatin in Combination as First-Line Chemotherapy for Advanced Epithelial Ovarian Cancer. Journal of Clinical Oncology. 17(7). 2069–2069. 66 indexed citations
10.
Harrington, Kevin J., et al.. (1997). Cancer-related thromboembolic disease in patients with solid tumours: A retrospective analysis. Annals of Oncology. 8(7). 669–673. 27 indexed citations
11.
Thomas, H., et al.. (1996). An inbred colony of oncogene transgenic mice: diversity of tumours and potential as a therapeutic model. British Journal of Cancer. 73(1). 65–72. 7 indexed citations
12.
Thomas, H., et al.. (1995). Proliferating cell nuclear antigen (PCNA) immunostaining - a prognostic factor in ovarian cancer?. British Journal of Cancer. 71(2). 357–362. 36 indexed citations
13.
Thomas, H. & H Lambert. (1992). Solitary cerebral metastases from gynaecological malignancy: The case for radical therapy. Clinical Oncology. 4(2). 133–134. 4 indexed citations
14.
Thomas, H., Claire Barton, Aman Saini, Angus Dalgleish, & Jonathan Waxman. (1992). Sequential interleukin-2 and alpha interferon for renal cell carcinoma and melanoma. European Journal of Cancer. 28(6-7). 1047–1049. 4 indexed citations
15.
Thomas, H. & Karol Sikora. (1991). New Therapeutic Modalities for Cancer. Acta Oncologica. 30(1). 107–120. 4 indexed citations
16.
Thomas, H., et al.. (1990). Ascites Induced by Interleukin‐2 in the Treatment of Renal Cancer. British Journal of Urology. 65(3). 303–305. 3 indexed citations
17.
Waxman, Jonathan & H. Thomas. (1990). Is the outlook changing for patients with renal cell cancer?. European Journal of Cancer and Clinical Oncology. 26(8). 860–862. 2 indexed citations
18.
Waxman, Jonathan & H. Thomas. (1990). Metastatic renal cell cancer—is the outlook really improving?. Postgraduate Medical Journal. 66(776). 435–440. 1 indexed citations
19.
Waxman, Jonathan, J. Sandow, H. Thomas, Nicholas D. James, & G. Williams. (1989). A pharmacological evaluation of a new 3-month depot preparation of buserelin for prostatic cancer. Cancer Chemotherapy and Pharmacology. 25(3). 219–220. 3 indexed citations
20.
Hird, V, H. Thomas, John S. Stewart, & Agamemnon A. Epenetos. (1989). Malignant ascites: review of the literature, and an update on monoclonal antibody-targeted therapy. European Journal of Obstetrics & Gynecology and Reproductive Biology. 32(1). 37–45. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Gargano Breakdown of academic impact, for papers by D S Alberts Breakdown of academic impact, for papers by Chan Kk Breakdown of academic impact, for papers by Ruifang Xu Breakdown of academic impact, for papers by Yoshiya Miyahara Breakdown of academic impact, for papers by Ami Vaidya Breakdown of academic impact, for papers by Stephanie A. Sullivan Breakdown of academic impact, for papers by Sachiko Kimura Breakdown of academic impact, for papers by S. Matthews Breakdown of academic impact, for papers by Ya-Min Cheng
Rankless by CCL
2026